We publish news of technology innovations, investment opportunities, together with updates from spin-out & start-up companies and licensees
OUI's quarterly round up of news and data, plus our year-end stats.
Oxford University spinout Vaccitech will use investment from GV, Oxford Sciences Innovation and Sequoia China to advance a universal flu vaccine and address other diseases requiring cellular immune activation.
Oxford spinout Oxehealth secures £3m in early-stage funding backed by IP Group.
Augmented and virtual reality spinout 6Degrees revealed as 150th spinout firm from Oxford University.
Gene therapy spinout Nightstar Therapeutics signs deal with Oxford University Innovation to tackle Stargardt disease.
Oxford University Innovation’s digital health deal with Drayson Technologies and Oxford University Hospitals celebrated at annual OBN awards.
Find out more about what's going on in the Oxford innovation ecosystem with our quarterly report.
Onfido, one of the first startups to come out of the OUI incubator, raises $30m series C.
The Oxford University spinout, launched in 2014, files plans with the SEC to go public on the NASDAQ.
In Q2 2017, Oxford companies raised £93m, OUI was named TTO of the Year, and the £1.2bn contribution to the global economy from Oxford's commercialisation capabilities was highlighted in a new report.
